RNTX
Price
$1.12
Change
-$0.05 (-4.27%)
Updated
Feb 13 closing price
Capitalization
28.65M
Intraday BUY SELL Signals
VSTM
Price
$5.82
Change
-$0.02 (-0.34%)
Updated
Feb 13 closing price
Capitalization
438.36M
Intraday BUY SELL Signals
Interact to see
Advertisement

RNTX vs VSTM

Header iconRNTX vs VSTM Comparison
Open Charts RNTX vs VSTMBanner chart's image
Rein Therapeutics
Price$1.12
Change-$0.05 (-4.27%)
Volume$84.75K
Capitalization28.65M
Verastem
Price$5.82
Change-$0.02 (-0.34%)
Volume$2.28M
Capitalization438.36M
RNTX vs VSTM Comparison Chart in %
RNTX
Daily Signal:
Gain/Loss:
VSTM
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RNTX vs. VSTM commentary
Feb 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNTX is a Hold and VSTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 15, 2026
Stock price -- (RNTX: $1.12 vs. VSTM: $5.82)
Brand notoriety: RNTX and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNTX: 47% vs. VSTM: 121%
Market capitalization -- RNTX: $28.65M vs. VSTM: $438.36M
RNTX [@Biotechnology] is valued at $28.65M. VSTM’s [@Biotechnology] market capitalization is $438.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNTX’s FA Score shows that 0 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • RNTX’s FA Score: 0 green, 5 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, both RNTX and VSTM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNTX’s TA Score shows that 3 TA indicator(s) are bullish while VSTM’s TA Score has 5 bullish TA indicator(s).

  • RNTX’s TA Score: 3 bullish, 7 bearish.
  • VSTM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VSTM is a better buy in the short-term than RNTX.

Price Growth

RNTX (@Biotechnology) experienced а -1.75% price change this week, while VSTM (@Biotechnology) price change was -12.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.41%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was +22.89%.

Industries' Descriptions

@Biotechnology (+2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VSTM($438M) has a higher market cap than RNTX($28.7M). RNTX YTD gains are higher at: -3.448 vs. VSTM (-24.611). RNTX has higher annual earnings (EBITDA): -23.77M vs. VSTM (-238.62M). VSTM has more cash in the bank: 138M vs. RNTX (4.05M). VSTM has higher revenues than RNTX: VSTM (13.4M) vs RNTX (0).
RNTXVSTMRNTX / VSTM
Capitalization28.7M438M7%
EBITDA-23.77M-238.62M10%
Gain YTD-3.448-24.61114%
P/E RatioN/AN/A-
Revenue013.4M-
Total Cash4.05M138M3%
Total DebtN/A89.5M-
FUNDAMENTALS RATINGS
RNTX vs VSTM: Fundamental Ratings
RNTX
VSTM
OUTLOOK RATING
1..100
705
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6282
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
4050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VSTM's Valuation (61) in the Biotechnology industry is in the same range as RNTX (67) in the null industry. This means that VSTM’s stock grew similarly to RNTX’s over the last 12 months.

VSTM's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RNTX (100) in the null industry. This means that VSTM’s stock grew similarly to RNTX’s over the last 12 months.

VSTM's SMR Rating (100) in the Biotechnology industry is in the same range as RNTX (100) in the null industry. This means that VSTM’s stock grew similarly to RNTX’s over the last 12 months.

RNTX's Price Growth Rating (62) in the null industry is in the same range as VSTM (82) in the Biotechnology industry. This means that RNTX’s stock grew similarly to VSTM’s over the last 12 months.

RNTX's P/E Growth Rating (100) in the null industry is in the same range as VSTM (100) in the Biotechnology industry. This means that RNTX’s stock grew similarly to VSTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RNTXVSTM
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 20 days ago
77%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
RNTX
Daily Signal:
Gain/Loss:
VSTM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RAIL13.240.40
+3.12%
FreightCar America
BSX74.730.61
+0.82%
Boston Scientific Corp
HOMB29.35-0.12
-0.41%
Home BancShares
DAIO2.90-0.15
-4.92%
Data I/O Corp
NVCR10.99-1.54
-12.29%
NovoCure Limited

RNTX and

Correlation & Price change

A.I.dvisor tells us that RNTX and NNVC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNTX and NNVC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNTX
1D Price
Change %
RNTX100%
-4.27%
NNVC - RNTX
26%
Poorly correlated
+7.53%
PRLD - RNTX
26%
Poorly correlated
-0.45%
VSTM - RNTX
26%
Poorly correlated
-0.34%
GNTA - RNTX
25%
Poorly correlated
-1.12%
IKT - RNTX
25%
Poorly correlated
+1.83%
More

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with ZLDAF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then ZLDAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
-0.34%
ZLDAF - VSTM
47%
Loosely correlated
N/A
RZLT - VSTM
45%
Loosely correlated
+5.79%
ARCT - VSTM
43%
Loosely correlated
+0.56%
CUE - VSTM
43%
Loosely correlated
+2.20%
TCRX - VSTM
43%
Loosely correlated
-0.25%
More